Fosun Pharma to sell 5% Gland Pharma stake worth Rs 2,279 crore in block deal
Gland Pharma's promoter Fosun Pharma plans to divest its 5% equity holding via a block deal valued at Rs 2,279.5 crore.
Fosun Pharma Industrial, the promoter of Gland Pharma, is launching a block deal to offload 5% of its shares. The transaction involves selling approximately 42.7 million shares at a floor price of Rs 2,763 per share. This results in an offer size pegged at Rs 2,279.5 crore. As of June 30, 2026, Fosun Pharma held 8,53.9 million shares representing a 51.77% stake. The deal includes a lock-up period for further sales lasting up to 12 months. Gland Pharma shares settled at Rs 2,904.85 on September 3, 2026, reflecting a 69.96% gain year-to-date with a market capitalization of Rs 47,920.34 crore. On September 1, 2026, the company confirmed a routine Good Manufacturing Practice inspection at its Visakhapatnam facilities by the USFDA between August 24 and September 1, 2026.
